MET stock forecast, quote, news & analysis

Key Takeaways

• MetLife raised its quarterly dividend by 4.4% to $0.5925 per share, signaling strong cash flow confidence.
• The stock has gained significantly in recent weeks, approaching its 52-week high amid positive investor sentiment.
• Q1 2026 earnings, due soon, carry expectations of EPS (earnings per share) at $2.23, up 13.8% year-over-year.
• Analysts maintain a Moderate Buy consensus with an average price target of $89.31.
• Previewed Q1 variable investment income of $475–$525 million supports full-year guidance of about $1.6 billion.
• Recent analyst adjustments include lowered price targets but retained Buy/Overweight ratings.

Current Market Snapshot

MetLife (MET) stock has demonstrated resilience in recent trading sessions, hovering near the upper end of its 52-week range between $67.33 and $83.85. With a market capitalization exceeding $51 billion and a trailing P/E (price-to-earnings) ratio of 17.03, the shares reflect steady performance year-to-date and over the past year. Trading volume remains consistent with averages, underscoring sustained investor interest. The forward dividend yield of approximately 2.95% enhances its appeal for income-focused portfolios, while a beta of 0.77 indicates lower volatility compared to the broader market. This positioning highlights MET's role as a stable player in the insurance sector amid fluctuating economic conditions.

Trending AI Robots

Tickeron’s Trending AI Robots page curates the top-performing AI trading bots from a library of over 351 models that trade thousands of tickers across diverse strategies, timeframes, and market conditions. These bots employ advanced technical and fundamental analyses, real-time signals, and risk management to outperform benchmarks like the S&P 500. Currently featuring 25+ standout performers, they showcase impressive stats: annualized returns ranging from +32% to +127%, win rates of 50–69%, profit factors between 1.5 and 3.3, and profit-to-drawdown ratios up to 17. Focused on high-growth sectors like semiconductors, AI infrastructure, industrials, and space, bots use styles such as swing trading, short-term AI/ML agents (5min to 60min), and double agents with corridor take-profits (TP 3%/SL 2%). Investors can explore these for automated, data-driven opportunities tailored to volatile markets. Visit the page to evaluate and copy trade the most suitable bots today.

Recent Developments Driving MET Price Action

MetLife's stock has climbed over 12% in the past 30 days, propelled by key announcements reinforcing financial health and shareholder returns. The board approved a second-quarter 2026 common stock dividend of $0.5925 per share, a 4.4% increase from the prior quarter, prompting a 5.3% share price surge in the immediate aftermath. This move highlights robust cash generation and commitment to dividends, boosting sentiment among income-oriented investors.

Anticipation builds for Q1 2026 earnings on May 6, with Wall Street forecasting EPS of $2.23 (13.8% year-over-year growth) and revenue of $19.2 billion (2% increase). Higher investment income is expected to aid results, as previewed variable investment income hit $475–$525 million pre-tax for the quarter, aligning with full-year guidance near $1.6 billion. This supports expectations of continued net investment income (NII) strength in a higher-rate environment.

Analyst activity has been mixed but constructive. BofA Securities maintained a Buy rating while trimming its price target to $99 from $103 on April 14. Morgan Stanley also cut its target to $93 from $101 but kept an Overweight stance. The consensus remains Moderate Buy, with an average target of $89.31, implying upside potential from current levels around $80.

On April 14, MetLife cautioned shareholders against a "mini-tender" offer from Potemkin Limited at $44.20 per share—41% below the then-closing price of $75.36—aiming to protect investor value. Earlier in the month, reports noted leadership transitions, potentially streamlining operations. These factors, alongside sector tailwinds from stable interest rates and economic resilience, have driven MET's outperformance versus peers, with shares rebounding from mid-April levels near $77 to recent highs.

2026 Outlook and Key Factors to Monitor

As MetLife navigates 2026, investors should track investment income trends, with full-year variable guidance at approximately $1.6 billion underscoring sensitivity to interest rates and portfolio yields. Consensus estimates project EPS growth of 11.6% to $9.85, though revenues may dip slightly by 0.8% to $78.24 billion, reflecting premium dynamics and expense discipline. The insurance sector faces macroeconomic pressures like potential rate cuts, inflation persistence, and a K-shaped economic recovery, where divergent growth paths could impact policy demand and claims.

Opportunities lie in MetLife's diversified operations across group benefits, retirement, and Asia/Latin America segments, bolstered by strategic asset management expansions. Regulatory shifts, such as capital requirements under frameworks like CET1 (Common Equity Tier 1), and competitive positioning in annuities amid aging demographics warrant attention. Technology integration, including AI for risk assessment, may enhance efficiency. Balanced monitoring of credit spreads, equity volatility, and geopolitical risks will be crucial for assessing long-term resilience without presuming outcomes.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations